Comparable Clinical Outcomes in Patients with HER2 ‐mutant and EGFR‐mutant Lung Adenocarcinomas

In conclusion, lung ADC harboring HER2 mutations showed distinct characteristics from other driver mutations, including increased chemosensitivity with in advanced stage disease. This article is protected by copyright. All rights reserved.

Source: Genes, Chromosomes and Cancer - January 7, 2017 Category: Cancer & Oncology Authors: Chien ‐Hung Gow, Hou‐Tai Chang, Chor‐Kuan Lim, Chao‐Yu Liu, Jin‐Shing Chen, Jin‐Yuan Shih Tags: Research Article Source Type: research